Medical device company CVRx, Inc. has released its performance guidance for fiscal year 2026.

The company anticipates that total annual revenue will range between $63 million and $67 million. In terms of profitability, the company has provided a gross margin expectation of 85% to 87%, demonstrating confidence in its product portfolio's profitability. Meanwhile, the company expects operating expenses for the entire year to reach $103 million to $107 million, reflecting its ongoing investment plans in research and development, sales, and marketing.